Photobiomodulation Decreases Hyperalgesia in Complex Regional Pain Syndrome: An Experimental Mouse Model Subjected to Nicotine

Background and Objectives Complex regional pain syndrome (CRPS) is defined as an extreme and chronic pain condition, and photobiomodulation has relevance as a complementary treatment for CRPS. The objective of this study was to verify the effects of photobiomodulation (PBMT) therapy protocols at two...

Full description

Saved in:
Bibliographic Details
Published in:Lasers in surgery and medicine 2020-11, Vol.52 (9), p.890-896
Main Authors: Rodrigues, Mariana, Cardoso, Ramon B., Kuriki, Heloyse U., Marcolino, Alexandre M., Oliveira Guirro, Elaine Caldeira, Barbosa, Rafael I.
Format: Article
Language:English
Subjects:
Ankle
Chronic pain
Complex regional pain syndrome
Edema
Hyperalgesia
Ischemia
Lasers
Light therapy
low‐level laser therapy
neuropathic pain
Nicotine
Pain
Pain perception
reflex sympathetic dystrophy syndrome
Reperfusion
Statistical analysis
Wavelengths
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Objectives Complex regional pain syndrome (CRPS) is defined as an extreme and chronic pain condition, and photobiomodulation has relevance as a complementary treatment for CRPS. The objective of this study was to verify the effects of photobiomodulation (PBMT) therapy protocols at two wavelengths 660 and 830 nm, associated or not to nicotine in complex regional pain syndrome type I (CRPS‐I). Study Design/Materials and Methods Sixty‐four Swiss mice were divided into the following groups: (i) Naive, (ii) Sham, (iii) Control, (iv) 660 nm, (v) 830 nm, (vii) Nicotine, (vii) Nicotine/660 nm, and (viii) Nicotine/830 nm. CRPS‐I was induced in an experimental ischemia/reperfusion model by affixing an elastic ring, proximal to the ankle joint of the right hind mouse paw, for 3 hours. Nicotine, in the respective groups was administered for 28 days prior to the induction of CRPS‐I. PBMT was applied immediately after the procedure and for 20 consecutive days. The animals were evaluated for mechanical hyperalgesia, thermal hyperalgesia, paw edema at baseline and for 7, 14, and 21 days. Statistical analyses comprised a mixed‐effects model, using the Tukey post hoc test (P 
ISSN:0196-8092
1096-9101
DOI:10.1002/lsm.23240